Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 9/20 | 0.49 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.49 |
| ▸ | CHRNA3 | P32297 | 4/20 | 0.49 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.49 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6322967 | 1.00 | KCNA3 (0.50) | KCNA3CHRNA7CHRNB4CHRNA3CHRNA10 | |
| Water SCHEMBL9515038 | 0.93 | CHRNA7 (0.44) | KCNA3CHRNA7CHRNB4CHRNA3CHRNA10 | |
| SCHEMBL13686299 | 0.88 | MAOB (0.48) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL18087646 | 0.82 | RELA (0.48) | KCNA3CHRNA7CHRNB4CHRNA3CHRNA10 | |
| SCHEMBL17736104 | 0.82 | RELA (0.48) | KCNA3CHRNA7CHRNB4CHRNA3CHRNA10 | |
| SCHEMBL13899907 | 0.79 | RELA (0.55) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL13686297 | 0.78 | ALDH1A1 (0.39) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL8093709 | 0.78 | MEN1 (0.50) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL25251262 | 0.76 | MAOB (0.41) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 | |
| SCHEMBL2098848 | 0.76 | RELA (0.46) | CHRNA7CHRNB4CHRNA3CHRNA10CHRNA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257678-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2023-08-17 | — | — | US | disclosed |
| EP-3746420-B1 | ENOL ETHER PROPERFUME | FIRMENICH & CIE (CH) | 2023-08-16 | — | — | EP | disclosed |
| US-11667869-B2 | Enol ether pro perfume | FIRMENICH SA (CH) | 2023-06-06 | — | — | US | disclosed |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2021-04-22 | — | — | US | disclosed |
| EP-3746420-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2020-12-09 | — | — | EP | disclosed |
| WO-2019243501-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667869-B2 | Enol ether pro perfume | CYP2E1, ACADM, PEF1 | KCNA3 2058/4885CHRNA7 2432/4885CHRNB4 2176/4885 |
| US-20230257678-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | KCNA3 1176/4885CHRNA7 2343/4885CHRNB4 2676/4885 |
| US-20210115354-A1 | ENOL ETHER PROPERFUME | CYP2E1, ACADM, ALDH5A1 | KCNA3 2645/4885CHRNA7 3366/4885CHRNB4 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.